Cite
Supplementary Methods from Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition
MLA
Takeshi Shimamura, et al. Supplementary Methods from Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3d04c11aa9fac1c57ded76793bc92ddb&authtype=sso&custid=ns315887.
APA
Takeshi Shimamura, Geoffrey I. Shapiro, Pasi A. Jänne, Kwok-Kin Wong, Julián Carretero, Fatima Al-shahrour, Tarun B. Patel, Chunxiao Xu, Eiki Kikuchi, Jeffrey H. Becker, Cloud P. Paweletz, Yanan Kuang, Inés Pulido, Marzia Capelletti, & Margaret Soucheray. (2023). Supplementary Methods from Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition.
Chicago
Takeshi Shimamura, Geoffrey I. Shapiro, Pasi A. Jänne, Kwok-Kin Wong, Julián Carretero, Fatima Al-shahrour, Tarun B. Patel, et al. 2023. “Supplementary Methods from Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3d04c11aa9fac1c57ded76793bc92ddb&authtype=sso&custid=ns315887.